Hereditary leiomyomatosis and renal cell cancer (HLRCC)
Log in to starLast updated Nov 3, 2026
A young woman with numerous painful skin nodules (leiomyomas) and uterine fibroids requiring early hysterectomy is found to have an aggressive renal tumor. Genetic testing reveals a FH variant.
AD; FH (fumarate hydratase)
- Krebs cycle enzyme; tumor suppressor: tumors carry the germline variant plus somatic loss of the other allele
- Biallelic germline variants cause fumarate hydratase deficiency, a recessive metabolic disorder
Fumarate hydratase is a homotetrameric Krebs cycle enzyme that converts fumarate to L-malate. HLRCC behaves as a tumor suppressor disorder: tumors carry the germline variant plus a somatic variant or loss of heterozygosity of the other allele, so the tumor cells lose fumarate hydratase function.
Without it, fumarate accumulates and the cell rewires its metabolism. FH-deficient kidney cancer shows impaired oxidative phosphorylation and a shift to aerobic glycolysis (the Warburg effect). AMP-activated protein kinase falls, with lower p53 and cellular iron and stabilization of HIF-1 alpha, which raises VEGF and GLUT1. Fumarate also inhibits the prolyl hydroxylases that mark HIF for destruction, so the cell behaves as though it were hypoxic. Accumulated fumarate further impairs homologous recombination repair of double-strand breaks, a possible treatment target.
Genotype has two emerging correlations:
- Pheochromocytoma and paraganglioma: certain mostly missense variants (for example p.Glu53Lys, p.Arg74Ser, p.Ala117Pro) go with these tumors, and their carriers are less likely to have the leiomyomas and kidney cancer.
- Fumarate hydratase deficiency without tumors: some variants (for example p.Pro174Arg, p.Lys477dup) cause the recessive disorder in the biallelic state without the HLRCC tumor risk.
- Cutaneous leiomyomas (painful skin nodules)
- Uterine leiomyomas (fibroids, often early/severe)
- Renal cell carcinoma (type 2 papillary, aggressive)
- Often unilateral, solitary
- Highly aggressive - metastatic even when small
- Reed syndrome (cutaneous + uterine leiomyomas)
- Clinical suspicion from multiple cutaneous leiomyomas (skin biopsy confirms), early/severe uterine leiomyomas, or a type 2 papillary RCC
- Tumors and leiomyomas show loss of FH activity; supportive immunohistochemistry includes loss of FH staining and nuclear accumulation of 2-succinocysteine (2SC)
- Confirm with germline FH sequencing and deletion/duplication analysis (biallelic FH variants instead cause fumarase deficiency, a severe neurometabolic disorder)
- Annual renal imaging (MRI preferred)
- Aggressive treatment of any renal tumor (even small)
- Dermatologic and gynecologic surveillance
- No nephron-sparing surgery (due to aggressive nature)
HLRCC predisposes to "FUMAR": Fibroid Uterus (uterine leiomyoma, ~100%), Moles (skin leiomyoma, ~75%), Adrenal nodules (a rarer, less-established FH-related finding; FH is also a recognized pheochromocytoma/paraganglioma gene), Renal cell carcinoma (~15%, type 2 papillary). The defining HLRCC triad is cutaneous leiomyomas, uterine leiomyomas, and type 2 papillary RCC.
"Fibroids and Fee-o (pheo) in FH": FH = fumarate hydratase. Your kidney helps regulate hydration/volume status, so RCC is associated with fumarate hydratase deficiency.